In prostate cancer (PC), PKIB is notably overexpressed in castration-resistant and aggressive subtypes, where it enhances cell growth and invasion by increasing the kinase activity of PKA-C and the phosphorylation of AKT [29]. Here, PKIB is linked to prostate cancer.